Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Phase II oxaliplatin-based regimen re-introduction in relapsed colon cancer after oxaliplatin adjuvant therapy
jRCTs041180118Phase 2Completed
- Sponsor
- Yakult Honsha
- Start
- Sep 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC), sponsored by Yakult Honsha. Primary endpoint: Progression-free survival. Started Sep 2013; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs041180118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180118.